Phase 2a/b read out by end of 2024 for market cap of $8M, if your thinking positive outcome, not sure there is equatable value on the asx right now.
But, from my understanding cash is pretty low per their last quarterly, is a cap raise imminent or perhaps I missed something?
Ann: Phase 2a/b clinical trial update, page-2
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.025(31.3%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 13.0¢ | 9.8¢ | $452.6K | 4.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7707 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 28571 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| ILA (ASX) Chart |